Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02869113 · ClinicalTrials.gov registry record · NA
Evaluation of the Stinging Potential of Sunscreen Products in Human Eyes
A NA study, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT02869113: Completed NA study, sponsored by Bayer.
NCT02869113 is a NA study that has completed, run by Bayer. The registered enrollment target is 65 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02869113, a NA study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
The objective of this study was to compare the human eye stinging potential of experimental formulas and an industry standard shampoo mixture. The study was conducted under the supervision of a Board Certified Ophthalmologist.
Interventions
- DRUG BAY98751 (Y65-110)
- DRUG BAY 98751 (Y65-102)
- DRUG BAY 98751 (Y65-106)
- DRUG Standard shampoo mixture (Control)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2015-01-23 |
| Est. Completion | 2015-01-24 |
| Phase | NA |
What the finished NCT02869113 record still lists
NCT02869113 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 4 interventions - of which BAY98751 (Y65-110) is the first listed.
NCT02869113 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02869113 about?
NCT02869113 is a clinical study titled "Evaluation of the Stinging Potential of Sunscreen Products in Human Eyes". The objective of this study was to compare the human eye stinging potential of experimental formulas and an industry standard shampoo mixture. The study was conducted under the supervision of a Board Certified Ophthalmologist.
What is the current status of trial NCT02869113?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2015-01-23. Estimated completion is 2015-01-24.
What interventions are being tested in trial NCT02869113?
The interventions under investigation include: BAY98751 (Y65-110) (DRUG), BAY 98751 (Y65-102) (DRUG), BAY 98751 (Y65-106) (DRUG), Standard shampoo mixture (Control) (DRUG).
Who is sponsoring clinical trial NCT02869113?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02869113's enrollment target sits among peer trials
65 1144th of 2000 higher than 854 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI